Context and Objective: Direct comparisons between types of dietary carbohydrate in terms of cardiometabolic risk indicators are limited. This study was designed to compare the effects of an isocaloric exchange of simple, refined, and unrefined carbohydrates on serum cardiometabolic risk indicators, adipose tissue inflammatory markers, and peripheral blood mononuclear cell (PBMC) fractional cholesterol efflux.
C ardiometabolic disorders, including cardiovascular disease, metabolic syndrome, and type 2 diabetes, are among the top 10 causes of mortality in the United States and worldwide, and despite decades of effort to reduce risk through lifestyle recommendations they continue to be a leading public health problem (1, 2) . Observational data have consistently identified an inverse association between dietary patterns rich in unrefined carbohydrate and cardiometabolic risk (3) (4) (5) . Some data suggest different metabolic responses to dietary simple carbohydrate, primarily monosaccharides and disaccharides, and refined carbohydrate, primarily the endosperm of grains devoid of the bran and germ (3) (4) (5) (6) (7) . Results from interventional studies focusing on markers of cardiometabolic health among different dietary carbohydrate types are limited, have heterogeneous findings, and reported few measures other than serum lipids and inflammatory marker concentrations (8) (9) (10) (11) (12) .
Obesity-related adipocyte hypertrophy and metabolic endotoxemia resulting from weight gain attract macrophage infiltration into adipose tissue, with subsequent chronic inflammation and secretion of proinflammatory cytokines (13) (14) (15) (16) . This effect exacerbates chronic systemic inflammation and insulin resistance and increases cardiometabolic risk (13, 15, 16) . Little is known about whether dietary carbohydrate type, particularly the major types currently on the market (simple, refined, and unrefined carbohydrates) alters this cascade of effects. The lack of information limits efforts to provide more precise dietary guidance intended to reduce cardiometabolic risk and spawns unsubstantiated claims about the relative risks or benefits of different types of carbohydrate-rich foods.
The primary aim of this study was to assess the relative effects of an isocaloric exchange of dietary simple, refined, and unrefined carbohydrate on serum cardiometabolic risk indicators. Secondary exploratory aims were to assess the effects on abdominal subcutaneous adipose tissue macrophage infiltration and inflammation markers and ex vivo peripheral blood mononuclear cell (PBMC) fractional cholesterol efflux. Our hypothesis was that the simple carbohydrate-enriched diet would result in the least favorable effects, followed by the refined carbohydrate and then the unrefined carbohydrateenriched diet phase.
Materials and Methods

Study population
Study participants [N = 11; 7 postmenopausal women and 4 men; 50 to 80 years; body mass index (BMI) 20 to 35 kg/m 2 ; LDL-cholesterol $2.6 mmol/L and otherwise apparently healthy] were recruited from the greater Boston area. Exclusion criteria included fasting glucose concentration .6.7 mmol/L; use of medications known to affect glucose or lipid metabolism; use of anticoagulants, anabolic steroids, hydrocortisone, and hormone therapy medications, nonsteroidal anti-inflammatory drugs or antihistamine therapies, omega-3 supplements, or fiber-containing dietary supplements; known chronic diseases (including cardiovascular disease, diabetes, kidney, thyroid, gastrointestinal, and liver diseases); untreated hypertension; lidocaine allergy; food allergies or aversions; tobacco use within the past 12 months; alcohol consumption $7 drinks per week; poor venous access; self-reported weight gain or loss $7 kg within the past 6 months before enrollment; and unwillingness to maintain body weight throughout the study period or adhere to the study protocol. The study was conducted in accordance with the Declaration of Helsinki guidelines. All procedures were approved by the Institutional Review Board of Tufts University/ Tufts Medical Center, and written informed consent was obtained from the study participants. The trial was registered at clinicaltrials.gov as NCT01610661 on 7 November 2011. The study was conducted between 2012 and 2015.
Recruitment and screening
Volunteers who responded to the study advertisements by telephone call or e-mail were provided with additional information about the study protocol. If they indicated an interest, a screening telephone interview to assess medical conditions and lifestyle behaviors was administered to determine potential eligibility. For those who did not report an exclusion criterion, a prescreening in-person appointment in the fasting state (12 hours) was scheduled to acquaint them with the procedures in Metabolic Research Unit and collect additional screening data. If the characteristics of a potential volunteer fell within the predetermined criteria, he or she was invited for a subsequent in-person screening in the fasting state (12 hours) to complete a full health screen. A total of 58 volunteers were screened for eligibility, and 15 participants were enrolled into the study. Four of these participants did not complete the study for the following reasons: noncompliance with study procedures (n = 3) and intolerance to the study diet (n = 1).
Study design and interventions
This was a randomized crossover design feeding study consisting of three 4.5-week diet phases, with a 2-week washout period between each dietary phase. All foods and beverages were provided to study participants. Participants visited the Metabolic Research Unit three times per week and were provided with one meal for consumption on-site and additional meals for consumption off-site. The variable component of the diets was the isocaloric exchange of simple, refined, and unrefined carbohydrate-containing foods. The experimental diets were designed from commonly available foods and were consistent with US ranges for simple and total carbohydrate intakes (17) (18) (19) . To eliminate potential seasonal variation, only foods available year-round were used to formulate the diets. By design, the macronutrient distribution was similar across the three diets (60% energy from carbohydrate, 15% from protein, 25% from fat) ( Table 1 ). The simple carbohydrate-enriched diet included a high proportion of foods made with sucrose or highfructose corn syrup. Given the compositional similarity between sucrose and high-sucrose corn syrup, ubiquitous and often simultaneous appearance in foods, and recent data suggesting little difference in metabolic response, total simple carbohydrate was defined as the two combined. The refined carbohydrateenriched diet included a high proportion of foods made with white rice, white bread, and white pasta. The unrefined carbohydrate-enriched diet included foods similar to the refined carbohydrate diet but made with whole grains. This resulted in approximately twice the fiber content in the unrefined carbohydrate-enriched diet than the other two diets. The diets were developed from the US Department of Agriculture National Nutrient Database (ndb.nal.usda.gov/ndb/) and the composition confirmed by chemical analyses (Covance Laboratories Inc., Madison, WI). The randomization sequence for each participant was generated by the statistician before the start of the study according to a block design, and assignment was based on enrollment date and time. Investigators and laboratory personnel were blinded to the random order.
Body weight and blood pressure were monitored weekly, and energy intake was adjusted, if necessary, to maintain a stable body weight (62 kg of screening body weight). Initial energy requirements were estimated via the Mifflin equation (20) . The caloric requirements were estimated by multiplying the resting energy expenditure by activity factor based on participants' self-reported physical activity level (activity factor of 1.5 for moderate activity and 1.7 for heavy activity). The amount of food in each of the experimental diets was provided to participants in 500-kcal increments and customized to meet individual energy requirements by the addition of a muffin containing 100 kcal that had a nutrient composition consistent with the appropriate diet. At the beginning of the study, participants were instructed to consume all foods and beverages provided and not supplement with any additional food or beverage except for water. Participants were encouraged to maintain their usual level of physical activity over the course of the study.
At the end of each diet phase, blood was drawn after a 12-hour fast on 3 consecutive days. On one of these days a nonfasting blood draw was collected 3 hours after the participant consumed an experimental breakfast consistent with the diet phase. A subcutaneous adipose tissue sample (1 to 2 g) in the abdominal region was obtained by liposuction by the study physician on one of these days.
Biochemical measures
Blood samples were allowed to clot at room temperature for 30 minutes, and serum was separated by centrifugation at 1500g at 4°C for 20 minutes. Serum total cholesterol, highdensity lipoprotein (HDL) cholesterol, and triglyceride concentrations were measured on an AU400e automated analyzer (Beckman Coulter, Brea, CA; assay coefficient of variation ,3%) with enzymatic reagents (Beckman Coulter). Low-density lipoprotein (LDL) cholesterol concentration was calculated via the Friedewald equation (21). Very-low-density lipoprotein (VLDL) cholesterol and non-HDL cholesterol were calculated as follows: VLDL cholesterol = triglycerides/2.2, and non-HDL cholesterol = total cholesterol -HDL cholesterol. 
Adipose tissue processing
Immediately after liposuction the adipose tissue was washed with 0.9% saline (Thermo Fisher Scientific, Waltham, MA), cleaned to remove blood clots or vessels, and weighed. The tissue was minced into 5-to 10-mg fragments with surgicalgrade scissors. Approximately 200 mg of tissue was incubated with 1.5 mL M199 media (Sigma-Aldrich, St. Louis, MO) containing 1% bovine serum albumin (BSA; Sigma-Aldrich) in a 37°C water bath with a shaker for 3 hours. Thereafter, the media was stored at 280°C to assess cytokine secretion. Approximately 100 mg of tissue was fixed for 24 hours in z-fix solution (Anatech LTD, Battle Creek, MI) and transferred into 2 mL 13 PBS (Thermo Fisher Scientific) for storage at 4°C until histologic analysis and adipocyte area measurement. The remaining adipose tissue was immediately stored in liquid nitrogen for gene expression analysis. sequences for CD14, CD68, adiponectin, leptin, IL-6, and serum amyloid A-1 (SAA-1) were based on published studies. Peptidylprolyl isomerase A was used as a reference gene, and relative expression levels were calculated.
Gene expression in adipose tissue
Cytokine secretion
Leptin and IL-6 concentrations in adipose tissue culture media were measured with a DuoSet ELISA Development Kit (R&D Systems), and adiponectin concentrations were measured with a Human Total Adiponectin/Acrp30 Quantikine ELISA Kit (R&D Systems) according to manufacturer's instructions.
Fractional cholesterol efflux
Fractional cholesterol efflux was determined in nine participants via a modified protocol (23) . Briefly, PBMCs were isolated and incubated at 37°C for 8 days in RPMI 1640 (Invitrogen) supplemented with 10% autologous serum for macrophage differentiation. The macrophages were then incubated for 24 hours in RPMI 1640 supplemented with 10% autologous serum, 50 mg/mL oxidized LDL cholesterol (Intracel Resources, Frederick, MD), and 2.5 mCi/mL [ 3 H] cholesterol (Perkin Elmer, Waltham, MA). After an additional 6-hour incubation in RPMI 1640 supplemented with 0.2% BSA, the cells were incubated in RPMI 1640 containing 0.2% BSA in the absence or presence of acceptor HDL (50 mg/mL, isolated from human plasma) and apolipoprotein A-I (10 mg/mL; SigmaAldrich) for 14 hours. With media and cell lysate data, the fractional cholesterol efflux was calculated and corrected for total protein, determined via the bicinchoninic acid assay. Two participants had missing values in the unrefined carbohydrateenriched diet phase because of an inadequate number of PBMCs.
Statistical analyses
The data were analyzed in SAS for Windows (version 9.4; SAS Institute, Cary, NC). Data were tested for normality (PROC UNIVARIATE) before statistical analysis. A repeatedmeasures ANOVA model (PROC MIXED) was used to test the differences in all outcome measures between diet phases. The model included diet and covariates (diet phase, sequence, age, BMI, sex) as the main effect and participant as the random effect. The Tukey-Kramer method was used for post hoc analyses. In the model to test the differences in body weight and change in body weight from start to end of each diet phase, we did not include BMI as a covariate because it was generated from the body weight data. Correlations between mean adipocyte area and adipose tissue macrophage infiltration and inflammatory markers at the end of each diet phase were analyzed via Pearson or Spearman correlation (PROC CORR) based on normality. Reported are the data for all participants who completed all interventions, with the exception of ex vivo PBMC fractional cholesterol efflux, for which samples were available from only nine participants. Data are presented as least squares means (95% confidence intervals). Statistical significance was accepted at P # 0.05.
Results
Baseline characteristics of study participants
By design, the participants were older adults (mean age of 65 years) ( Table 2 ). The mean BMI was on the border between the overweight and obese ranges. Participants had elevated mean waist circumference, waistto-hip ratio, and fasting serum glucose, triglycerides, total cholesterol, and LDL cholesterol concentrations based on the metabolic syndrome criteria (24) . By design, body weights were stable throughout the study. The mean body weight (P = 0.43) and absolute change in body weight from start to end of each diet phase (P = 0.32) were similar between diet phases.
Effect of carbohydrate type on fasting serum cardiometabolic risk indicators and ex vivo PBMC fractional cholesterol efflux Fasting serum total cholesterol (6% and 6%, respectively; P , 0.01), LDL cholesterol (6% and 10%, respectively; P , 0.01), and non-HDL cholesterol concentrations (8% and 8%, respectively; P , 0.01) were higher at the end of the refined than simple and unrefined carbohydrate-enriched diet phases (Table 3) . Fasting serum HDL cholesterol and VLDL cholesterol concentrations were similar between diet phases (Table 3) . Because of the lack of diet effect on HDL cholesterol concentration, the refined carbohydrate-enriched diet resulted in a higher total cholesterol to HDL cholesterol ratio (5% and 5%, respectively; P , 0.01) and LDL cholesterol to HDL cholesterol ratio (8% and 8%, respectively; P = 0.01) than the simple and unrefined carbohydrate-enriched diet phases (Table 3 ). In addition, fasting serum triglyceride and NEFA concentrations, glucose homeostasis and insulin resistance measures (insulin and glucose concentrations, HbA1c, and HOMA-IR), and inflammatory markers (hsCRP and IL-6 concentrations) were similar between diet phases (Table 3) . A significant BMI effect was observed in the analysis of concentrations of HDL cholesterol, VLDL cholesterol, triglyceride, and insulin and total cholesterol to HDL cholesterol ratio. A significant age effect was observed in the analysis of glucose concentrations. Analysis with and without the significant covariates did not influence the statistical significance of the diet effect. Although ex vivo fractional cholesterol efflux from PBMC was lowest at the end of the simple carbohydrate phase relative to the other diet phases, there was variability between individuals, and the difference did not reach statistical significance (Table 3 ; P = 0.18).
Effect of carbohydrate type on postprandial serum cardiometabolic risk indicators
Postprandial serum lipid, lipoprotein, insulin, and blood glucose measures were similar between simple, refined, and unrefined carbohydrate-enriched diet phases, with the exception of NEFA concentrations, which were higher at the end of the unrefined carbohydrate compared with the simple and refined carbohydrate-enriched diet phases (Table 4 ; P , 0.01). None of the covariates had a significant effect on outcomes. Effect of carbohydrate type on adipose tissue macrophage infiltration and inflammatory markers Gene expression of macrophage infiltration markers CD14 and CD68, anti-inflammatory marker adiponectin, and proinflammatory markers leptin and IL-6 were similar, regardless of diet phase, except for SAA-1 expression, which was marginally higher (P = 0.06) at the end of the refined than the simple and unrefined carbohydrate-enriched diet phases (Table 5) . Adipose tissue ex vivo secretion of anti-inflammatory cytokine adiponectin and proinflammatory cytokine leptin was similar between the diet phases ( Table 5 ). Secretion of proinflammatory cytokine IL-6 trended toward being higher (P = 0.07) at the end of the simple compared with the refined and unrefined carbohydrate-enriched diet phases (Table 5 ). Adipocyte area was measured to determine whether it served as a covariate with regard to adipose tissue macrophage infiltration and inflammatory markers. Mean adipocyte area was 7608 6 1138 mm 2 , 8238 6 923 mm 2 , and 7712 6 1328 mm 2 after simple, refined, and unrefined carbohydrate-enriched diet phases, respectively. Mean adipocyte area was not correlated with changes in adipose tissue macrophage infiltration or inflammatory markers. None of the covariates had a significant effect on outcomes.
Discussion
Although much has been reported about the importance of dietary carbohydrate type, sometimes called dietary carbohydrate quality, and chronic disease risk, these data are limited primarily to observational studies (3-7). Few interventional trials have directly compared the effects of different food-based forms of dietary carbohydrate on cardiometabolic risk indicators. Of the studies available, they have for the most part been limited to measures of serum lipid, lipoproteins, and inflammation markers (8) (9) (10) (11) (12) . This limitation may lead to an underestimation of the actual impact of different carbohydrate types on cardiometabolic risk. Our study was designed to address this limitation by measuring serum cardiometabolic risk indicators and exploring adipose tissue macrophage infiltration and inflammation markers and ex vivo PBMC fractional cholesterol efflux. Fasting serum total, LDL, and non-HDL cholesterol concentrations and the total cholesterol to HDL cholesterol and LDL cholesterol to HDL cholesterol ratios were higher at the end of the refined than the simple and unrefined carbohydrate-enriched diet phases. These data suggest that the least favorable cardiometabolic risk status occurred in response to the former rather than latter diet phases, contrary to our hypothesis. If replicated, this finding raises challenging questions related to food-based dietary recommendations.
With regard to the adverse effects of the refined carbohydrate-enriched diet on serum fasting LDL cholesterol and non-HDL cholesterol concentrations compared with the unrefined carbohydrate-enriched diet, these findings are consistent with those previously reported for whole-grain foods compared with refinedgrain foods (11, 25, 26) . The mechanism has been attributed, in part, to the ability of fiber to bind cholesterol, impeding cholesterol absorption and bile acid reabsorption. In addition to fiber, modulation of gut microbiota may also be involved as an underlying mechanism. Whole-grain foods have been reported to reduce plasma LDL cholesterol concentrations with a concurrent increase in the relative abundance of fecal Bifidobacterium and Lactobacillus, which may contribute to short-chain fatty acid production and bile acid deconjunction (27) . The resulting increase in bile acid excretion through both fiber and gut bacteria collectively is thought to contribute to an upregulation of hepatic LDL receptors and subsequent uptake of LDL cholesterol from the circulation (26, 28) . Of note, enriching diets with different types of carbohydrate also resulted in differences in micronutrient content through the effects of milling and enrichment, or different types of specific foods rich in the different carbohydrate types (29) . We cannot rule out the possibility these factors may have influenced the study outcomes. Similar effects of the simple and unrefined carbohydrate-enriched diets were unexpected and remain unexplained. The results from earlier studies investigating the isocaloric exchange of sucrose and starch on fasting LDL cholesterol concentration have been inconsistent. Two studies have reported that fasting LDL cholesterol concentrations were higher in participants consuming sucrose compared with starch (10, 30) , whereas two studies reported no significant differences (8, 9) . The lack of a significant differential effect of carbohydrate type in the current study on fasting serum concentrations of other lipid and lipoprotein, glucose homeostasis, and inflammatory markers is consistent with previous reports (8-12, 25, 31, 32) . Of interest, there was no significant effect of carbohydrate type on HDL-mediated ex vivo fractional cholesterol efflux from isolated PBMCs. We cannot rule out the possibility that the large variability between individuals obscured potential differences. The dietary perturbations assessed had little effect on postprandial serum lipid and lipoprotein measures or glucose homeostasis markers. These findings were also consistent with those of previous studies (8, 9, 31, 32) . Of particular interest was the effect of the experimental diets on postprandial hypertriglyceridemia because of the measure's potential relationship with cardiometabolic risk (33) . Although a single study has reported that isocaloric exchange of starch with sucrose was associated with postprandial hypertriglyceridemia (10), attributed to increased rates of de novo lipogenesis and decreased rates of fatty acid oxidation (10, 34) , similar studies have not reported a significant effect of an isocaloric exchange of fructose, sucrose, or whole grain with refined carbohydrate on postprandial hypertriglyceridemia (8, 9, 31, 32) . More consistently reported is the effect of dietary macronutrient composition on serum triglyceride, with higher-carbohydrate diets associated with higher concentrations (35, 36) . In the current study, by design, the carbohydrate content of the diets was similar. Postprandial serum NEFA concentration at the end of the unrefined carbohydrate-enriched diet phase was higher than at the end of the simple and refined carbohydrateenriched diet phases. The reason for this finding remains elusive.
Evidence from both animal and human studies has suggested that adipocyte hypertrophy triggers the infiltration of M1 macrophages into adipose tissue, with subsequent chronic inflammation in adipose tissue and secretion of proinflammatory cytokines, resulting in chronic systemic inflammation and insulin resistance (14) (15) (16) 37) . Changes in gene expression of these infiltrated macrophages have been reported as early as 2 weeks after a dietary intervention (38, 39) . However, available data for carbohydrate interventions are limited to comparisons between different forms of simple carbohydrate rather than comparisons between simple and complex carbohydrate. Consuming a fructose-sweetened beverage for 8 days resulted in a higher expression of abdominal subcutaneous adipose tissue adiponectin mRNA than beverages sweetened with glucose or highfructose corn syrup (39) . Expression of other inflammatory factor genes and adipose tissue macrophage infiltration were similar (39) . We found that carbohydrate type had little effect on subcutaneous adipose tissue macrophage infiltration, inflammatory gene expression, or ex vivo secretion of either anti-inflammatory or proinflammatory cytokines, within the timeframe studied. One explanation may be that visceral compared with subcutaneous adiposity is more strongly associated with dietary carbohydrate type (34, 39, 40) . Additionally, visceral adipose tissue secretes higher concentrations of monocyte chemoattractant protein-1 than subcutaneous adipose tissue, which may result in greater infiltration of macrophages and subsequent secretion of proinflammatory cytokines, making it more likely, were there differences between carbohydrate types, that those differences would be detected (39, 41) . However, visceral adipose tissue biopsy requires invasive surgical procedures and thus was not ethical in the current study.
There are several strengths in this study. The relative effects of an isocaloric exchange of diets enriched in simple, refined, and unrefined carbohydrate were directly compared, and at levels of carbohydrate intake consistent with current intake patterns (17) (18) (19) . The specific foods used to manipulate the diets are commonly consumed, enhancing the translational nature of the work. Targeted was a high-risk group of participants who would probably benefit from dietary modification to optimize cardiometabolic risk indicators. A broader range of cardiometabolic risk indicators was assessed than previously reported. However, limited sample volume and storage conditions prevented us from determining the concentration of the proinflammatory mediator TNF-a in serum or adipose tissue samples. Although the sample size was modest, the randomized crossover design provided adequate theoretical statistical power for the primary aim. The study may be underpowered for the secondary exploratory aims; however, it provides insight for future studies. Another limitation is that potential mechanistic explanations for differences in LDL cholesterol and non-HDL cholesterol concentrations were unexplored. Additional studies are needed to determine whether differences in gut microbiota and short-chain fatty acid production resulting from the dietary perturbations contributed to the differences observed in serum LDL and non-HDL cholesterol concentrations. In the absence of data in this area, controlled feeding studies with comprehensive analysis of gut microbiota are needed to capture the shifts in gut microbial diversity and abundance in response to different carbohydrate types.
In conclusion, higher serum total, LDL, and non-HDL cholesterol concentrations and total cholesterol-to-HDL cholesterol and LDL cholesterol-to-HDL cholesterol ratios were observed in response to the refined compared with simple and unrefined carbohydrate-enriched diets. Dietary carbohydrate type had no significant effect on markers of macrophage infiltration, inflammation, or ex vivo cytokine secretion in adipose tissue, serum markers of glucose homeostasis and inflammation, or ex vivo PBMC fractional cholesterol efflux. Were these data replicated in a larger study, it would have important implications for food-based dietary guidance intended to improve cardiometabolic health.
